|
|
|
Insider
Information: |
Greene Gabrielle E |
Relationship: |
Director |
City: |
Austin |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
159,425 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,757,189 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
159,425 |
|
|
Total
Value |
$6,757,189 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Whole Foods Market Inc |
WFM |
Director |
2017-08-28 |
0 |
2004-08-05 |
0 |
Premium* |
|
IndyMac Bancorp Inc |
IDMCQ |
Director, IndyMac Bank... |
2008-03-19 |
4,443 |
2007-01-23 |
0 |
Premium* |
|
Stage Stores Inc |
SSI |
Director |
2014-06-10 |
26,729 |
|
0 |
Premium* |
|
Brixmor Property Group Inc. |
BRX |
Director |
2021-06-01 |
37,161 |
|
0 |
Premium* |
|
MasterCard Inc A |
MA |
Director |
2024-06-18 |
4,878 |
2018-12-03 |
0 |
Premium* |
|
Cerevel Therapeutics Holdings, I... |
CERE |
|
2024-08-01 |
0 |
|
0 |
Premium* |
|
Warby Parker Inc. |
WRBY |
Director |
2024-06-07 |
84,024 |
|
0 |
Premium* |
|
Eli Lilly & Co |
LLY |
Director |
2024-09-16 |
2,190 |
2021-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
110 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SSI |
Stage Stores Inc |
Director |
|
2010-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,086 |
|
- |
|
BRX |
Brixmor Property Group In... |
Director |
|
2015-06-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
CERE |
Cerevel Therapeutics Hold... |
Director |
|
2020-10-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,270 |
|
- |
|
WRBY |
Warby Parker Inc. |
Director |
|
2021-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,556 |
|
- |
|
WRBY |
Warby Parker Inc. |
Director |
|
2021-09-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
9,173 |
|
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-10-16 |
4 |
A |
$616.64 |
$4,933 |
D/D |
8 |
1,714 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-08-21 |
4 |
A |
$550.50 |
$4,955 |
D/D |
9 |
1,694 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-09-18 |
4 |
A |
$571.28 |
$5,142 |
D/D |
9 |
1,706 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-12-18 |
4 |
A |
$579.76 |
$5,218 |
D/D |
9 |
2,069 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-07-15 |
4 |
A |
$950.46 |
$9,505 |
D/D |
10 |
2,165 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-05-15 |
4 |
A |
$434.51 |
$4,780 |
D/D |
11 |
1,659 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-06-20 |
4 |
A |
$451.95 |
$4,971 |
D/D |
11 |
1,674 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-07-17 |
4 |
A |
$447.14 |
$4,919 |
D/D |
11 |
1,685 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-06-17 |
4 |
A |
$885.01 |
$9,735 |
D/D |
11 |
2,155 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-08-19 |
4 |
A |
$921.81 |
$10,140 |
D/D |
11 |
2,176 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-09-16 |
4 |
A |
$923.54 |
$10,159 |
D/D |
11 |
2,190 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-04-17 |
4 |
A |
$372.35 |
$4,841 |
D/D |
13 |
1,648 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-02-20 |
4 |
A |
$755.66 |
$9,824 |
D/D |
13 |
2,098 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-03-18 |
4 |
A |
$762.66 |
$9,915 |
D/D |
13 |
2,115 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-04-15 |
4 |
A |
$750.77 |
$9,760 |
D/D |
13 |
2,128 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-05-20 |
4 |
A |
$783.18 |
$10,181 |
D/D |
13 |
2,141 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-01-17 |
4 |
A |
$357.74 |
$5,008 |
D/D |
14 |
1,599 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-02-21 |
4 |
A |
$327.51 |
$4,913 |
D/D |
15 |
1,614 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2023-03-20 |
4 |
A |
$333.60 |
$5,004 |
D/D |
15 |
1,635 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2024-01-16 |
4 |
A |
$634.57 |
$10,153 |
D/D |
16 |
2,085 |
0 |
- |
|
110 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|